{
    "name": "ioxilan",
    "comment": "Rx",
    "other_names": [
        "Oxilan"
    ],
    "classes": [
        "Iodinated Contrast Media"
    ],
    "source": "https://reference.medscape.com/drug/oxilan-ioxilan-343769",
    "pregnancy": {
        "common": [
            "Pregnancy Category: B",
            "Lactation: Not known, use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Not known, use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "The reaction to intrathecal administration can be fatal"
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to product or components",
                "Intrathecal administration (potentially fatal)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in severe renal impairment, combined renal/hepatic disease, thyroid dysfunction, multiple myeloma, anuria, pheochromocytoma, sickle cell, CHF, severe arterial/venous disease",
                "Severe cutaneous adverse reactions(SCAR), including Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), acute generalized exanthematous pustulosis (AGEP) and drug reaction with eosinophilia and systemic symptoms (DRESS), may develop from 1 hr to several weeks after intravascular contrast agent administration; reaction severity may increase and time to onset may decrease with repeat administration of contrast agent; prophylactic medications may not prevent or mitigate severe cutaneous adverse reactions; avoid administering product to patients with history of severe cutaneous adverse reaction to product",
                "May cause renal failure in patients with advanced vascular disease, diabetes; should be well hydrated before/after procedure",
                "Hypersensitivity to contrast medium, iodine",
                "Myocardial infarctions and stroke reported with angiographic procedures",
                "Avoid extravasation, especially in patients with severe arterial or venous disease",
                "Inhibits blood coagulation (less than ionic contrast media in vitro)",
                "Allergies (bronchial asthma, hay fever, food allergies)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Erythema",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Skin discoloration",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "Toxic epidermal necrolysis",
            "percent": null
        },
        {
            "name": "SJS",
            "percent": null
        },
        {
            "name": "TEN",
            "percent": null
        },
        {
            "name": "Acute generalized exanthematous pustulosis",
            "percent": null
        },
        {
            "name": "AGEP",
            "percent": null
        },
        {
            "name": "Drug reaction with eosinophilia and systemic symptoms",
            "percent": null
        },
        {
            "name": "DRESS",
            "percent": null
        }
    ]
}